Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

141
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
141
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

636
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
636
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

128
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
128
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

1000
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1000
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

209
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
209

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional Brain Localization of Botulinum Toxin Type A-Truncated Synaptosomal-Associated Protein 25 After Injection into the Rat Hind Paw.

Toxins·2026
Same author

Artificial intelligence in medicine: from molecular data analysis to clinical decision-making.

Croatian medical journal·2026
Same author

Perioperative changes in IgG and plasma N-glycosylation in children with acute appendicitis and elective surgery: a prospective study.

Croatian medical journal·2026
Same author

Early PCR-based DNA identification in a wartime mass-fatality event: archival reconstruction of the 1994 Duboki Jarak explosion.

Croatian medical journal·2026
Same author

When algorithms testify: artificial intelligence-driven DNA analysis, evidentiary standards, and criminal justice reform.

Croatian medical journal·2026
Same author

Systemic metabolic, hormonal, and glycomic remodeling during a 72-hour fast in healthy adults: a pilot study.

Croatian medical journal·2026

Related Experiment Video

Updated: Jan 4, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K

Challenges in anesthesia personalization: resolving the pharmacogenomic puzzle.

Lidija Bach-Rojecky1, Dalia Vađunec1, Marin Lozić2

  • 1Department of Pharmacology, University of Zagreb Faculty of Pharmacy & Biochemistry, Zagreb 10000, Croatia.

Personalized Medicine
|November 7, 2019
PubMed
Summary

Anesthesia drug doses and recovery times vary due to patient factors and genetics. Understanding genetic variations in drug targets and metabolism can explain unpredictable anesthesia outcomes.

Keywords:
anesthesiaepigeneticsgenotypeinhalational anestheticsintravenous anestheticsneuromuscular blockersopioidspharmacological characteristicssedatives

More Related Videos

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

4.5K
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

14.4K

Related Experiment Videos

Last Updated: Jan 4, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K
Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

4.5K
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

14.4K

Area of Science:

  • Pharmacogenomics
  • Anesthesiology
  • Clinical Pharmacology

Background:

  • Anesthesia practice often observes variability in patient responses, including dose requirements and recovery times.
  • While patient characteristics and drug properties are known factors, unpredictable variations persist.
  • Genetic factors influencing drug targets, transporters, and metabolism are increasingly recognized as significant contributors.

Purpose of the Study:

  • To critically review the pharmacological profiles of common anesthetic agents.
  • To explore the impact of genetic polymorphisms on the variability of anesthesia outcomes.
  • To elucidate the genetic basis for unpredictable responses to anesthesia.

Main Methods:

  • Literature review of anesthetic pharmacology.
  • Analysis of genetic polymorphisms affecting drug targets, transporters, and metabolic enzymes.
  • Discussion of clinical implications for anesthesia management.

Main Results:

  • Common anesthetic drugs exhibit diverse pharmacological characteristics.
  • Genetic variations (polymorphisms) in key genes can significantly alter drug response.
  • These genetic factors contribute to unpredictable variations in anesthetic efficacy and patient recovery.

Conclusions:

  • Patient-specific genetic makeup plays a crucial role in anesthesia outcomes.
  • Pharmacogenomic considerations are essential for optimizing anesthetic drug selection and dosing.
  • Further research into genetic influences can lead to more personalized and predictable anesthesia care.